Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction. 1998

H Lindenblatt, and E Krämer, and P Holzmann-Erens, and E Gouzoulis-Mayfrank, and K A Kovar
Pharmaceutical Institute of the University of Tübingen, Germany.

Two modifications of the HPLC-ED method with respect to extraction procedure used have been developed for psilocin, the active metabolite of psilocybin, in human plasma using either liquid-liquid extraction (LLE) or automated on-line solid-phase extraction (on-line SPE). Each type of the sample preparation required a different HPLC system followed by electrochemical detection at 650 to 675 mV. The limit of quantitation of both modifications was 10 ng/ml psilocin. There was no significant difference observable between the LLE and the on-line SPE in terms of method standard deviation (LLE 1.82%, on-line SPE 1.13%) and the analytical results. However, the advantages of on-line SPE in addition to different selectivity were less manual effort, smaller plasma volumes of 400 microl (LLE 2 ml) and a recovery of psilocin in human plasma of nearly 100% (LLE 88%). In contrast to a previous procedure both methods were rapid, simple and reliable and yielded high plasma recoveries. They were used successfully in the quantitation of psilocin in plasma samples obtained from healthy volunteers after p.o. administration of 0.2 mg psilocybin per kg body mass. Plasma concentration curves and pharmacokinetic parameters were calculated.

UI MeSH Term Description Entries
D011562 Psilocybin The major of two hallucinogenic components of the sacred Teonanacatl mushrooms (see PSILOCYBE), the other component being PSILOCIN. 1H-Indol-4-ol, 3-(2-(Dimethylamino)ethyl)-, Dihydrogen Phosphate (ester),Psilocybine,Psilocibin
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004563 Electrochemistry The study of chemical changes resulting from electrical action and electrical activity resulting from chemical changes. Electrochemistries
D006213 Hallucinogens Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. Hallucinogen,Hallucinogenic Agent,Hallucinogenic Drug,Hallucinogenic Substance,Psychedelic,Psychedelic Agent,Psychedelic Agents,Psychotomimetic Agent,Psychotomimetic Agents,Hallucinogenic Agents,Hallucinogenic Drugs,Hallucinogenic Substances,Psychedelics,Agent, Hallucinogenic,Agent, Psychedelic,Agent, Psychotomimetic,Agents, Hallucinogenic,Agents, Psychedelic,Agents, Psychotomimetic,Drug, Hallucinogenic,Drugs, Hallucinogenic,Substance, Hallucinogenic,Substances, Hallucinogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

H Lindenblatt, and E Krämer, and P Holzmann-Erens, and E Gouzoulis-Mayfrank, and K A Kovar
February 2000, Journal of chromatography. A,
H Lindenblatt, and E Krämer, and P Holzmann-Erens, and E Gouzoulis-Mayfrank, and K A Kovar
June 1999, Journal of chromatography. A,
H Lindenblatt, and E Krämer, and P Holzmann-Erens, and E Gouzoulis-Mayfrank, and K A Kovar
August 1999, Journal of chromatography. B, Biomedical sciences and applications,
H Lindenblatt, and E Krämer, and P Holzmann-Erens, and E Gouzoulis-Mayfrank, and K A Kovar
September 1984, Journal of neuroscience methods,
H Lindenblatt, and E Krämer, and P Holzmann-Erens, and E Gouzoulis-Mayfrank, and K A Kovar
December 1995, Journal of chromatography. B, Biomedical applications,
H Lindenblatt, and E Krämer, and P Holzmann-Erens, and E Gouzoulis-Mayfrank, and K A Kovar
July 1998, The Analyst,
H Lindenblatt, and E Krämer, and P Holzmann-Erens, and E Gouzoulis-Mayfrank, and K A Kovar
July 1999, Journal of chromatography. B, Biomedical sciences and applications,
H Lindenblatt, and E Krämer, and P Holzmann-Erens, and E Gouzoulis-Mayfrank, and K A Kovar
March 1999, Journal of chromatography. B, Biomedical sciences and applications,
H Lindenblatt, and E Krämer, and P Holzmann-Erens, and E Gouzoulis-Mayfrank, and K A Kovar
January 1998, Biomedical chromatography : BMC,
H Lindenblatt, and E Krämer, and P Holzmann-Erens, and E Gouzoulis-Mayfrank, and K A Kovar
January 2001, Veterinary research,
Copied contents to your clipboard!